What Are Gossamer Bio Inc.'s Key Financial Figures?
| Fiscal year | FY2025 ended December 31, 2025 | FY2024 ended December 31, 2024 | FY2023 ended December 31, 2023 | FY2022 ended December 31, 2022 |
|---|---|---|---|---|
| Revenue | $48 million | $115 million | $0 | $0 |
| Operating income | -$171 million | -$60 million | -$184 million | -$219 million |
| Operating margin | -352.2% | -52.2% | n/a | n/a |
| Net income | -$170 million | -$57 million | -$180 million | -$229 million |
| Net margin | -351.5% | -49.3% | n/a | n/a |
| Operating cash flow | -$171 million | -$3 million | -$159 million | -$187 million |
| Capital expenditures | $79,000 | $0 | $0 | $410,000 |
| Free cash flow | -$171 million | -$3 million | -$159 million | -$187 million |
Operating margin narrowed by 300.0 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was -$171 million against net income of -$170 million; cash generation fell short of reported earnings, which is worth reconciling in the cash flow statement.
What Does Gossamer Bio Inc.'s Balance Sheet Show?
| Cash and cash equivalents | $38 million |
|---|---|
| Long-term debt | Not reported |
| Total assets | $172 million |
| Total liabilities | $295 million |
| Shareholders' equity | -$123 million |
| Current ratio | 2.6x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Gossamer Bio Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001728117-26-000017 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Gossamer Bio Inc.'s revenue in fiscal 2025?
Gossamer Bio Inc. reported revenue of $48 million for the fiscal year ended December 31, 2025, according to its SEC filings.
What is Gossamer Bio Inc.'s operating margin?
Gossamer Bio Inc.'s operating margin was -352.2% in fiscal 2025: operating income of -$171 million on revenue of $48 million.
How much free cash flow did Gossamer Bio Inc. generate?
Operating cash flow of -$171 million less capital expenditures of $79,000 gives free cash flow of -$171 million for fiscal 2025.